Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 350
Single User License Price INR 24115
Corporate User License Price USD 1050
Corporate User License Price INR 72345
Site License Price USD 700
Site License Price INR 48230
Request a Quote

Report Title

Biotechnology in Europe

Quote Request for License Type
License Type Price  
Single User License USD 350
Site License USD 700
Enterprise Wide License USD 1050
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

Biotechnology in Europe


Quote Request for License Type
License Type Price  
Single User License USD 350
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

Biotechnology in Europe

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

Biotechnology in Europe



Executive Summary

Biotechnology in Europe

Summary

Biotechnology in Europe industry profile provides top-line qualitative and quantitative summary information including: market size (value 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Synopsis

Essential resource for top-line data and analysis covering the Europe biotechnology market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Key highlights

- The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.

- The European biotechnology industry had total revenues of USD 67.9bn in 2017, representing a compound annual growth rate (CAGR) of 5.7% between 2013 and 2017.

- The medical/healthcare segment was the industry's most lucrative in 2017, with total revenues of USD 43bn, equivalent to 63.4% of the industry's overall value.

- Italy has now overtaken the UK as the largest market in Europe and the uncertainties of Brexit are thought to have played a part in this. However, the industries in both countries remain close in terms of size, with Germany only slightly behind.

Scope

- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Europe

- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Europe

- Leading company profiles reveal details of key biotechnology market players' global operations and financial performance

- Add weight to presentations and pitches by understanding the future growth prospects of the Europe biotechnology market with five year forecasts

Reasons to buy

- What was the size of the Europe biotechnology market by value in 2017?

- What will be the size of the Europe biotechnology market in 2022?

- What factors are affecting the strength of competition in the Europe biotechnology market?

- How has the market performed over the last five years?

- What are the main segments that make up Europe's biotechnology market?

Table of Contents

Executive Summary 2

Market value 2

Market value forecast 2

Category segmentation 2

Geography segmentation 2

Market rivalry 2

Market Overview 7

Market definition 7

Market analysis 7

Market Data 9

Market value 9

Market Segmentation 10

Category segmentation 10

Geography segmentation 11

Market Outlook 12

Market value forecast 12

Five Forces Analysis 13

Summary 13

Buyer power 14

Supplier power 15

New entrants 16

Threat of substitutes 18

Degree of rivalry 19

Leading Companies 20

AstraZeneca PLC 20

Boehringer Ingelheim GmbH 23

F. Hoffmann-La Roche Ltd 26

Merck & Co., Inc. 30

Methodology 33

Industry associations 34

Related MarketLine research 34

Appendix 35

About MarketLine 35

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

List of Figures

Figure 1: Europe biotechnology industry value: USD billion, 2013-17

Figure 2: Europe biotechnology industry category segmentation: % share, by value, 2017

Figure 3: Europe biotechnology industry geography segmentation: % share, by value, 2017

Figure 4: Europe biotechnology industry value forecast: USD billion, 2017-22

Figure 5: Forces driving competition in the biotechnology industry in Europe, 2017

Figure 6: Drivers of buyer power in the biotechnology industry in Europe, 2017

Figure 7: Drivers of supplier power in the biotechnology industry in Europe, 2017

Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in Europe, 2017

Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in Europe, 2017

Figure 10: Drivers of degree of rivalry in the biotechnology industry in Europe, 2017

Figure 11: AstraZeneca PLC: revenues & profitability

Figure 12: AstraZeneca PLC: assets & liabilities

Figure 13: Boehringer Ingelheim GmbH: revenues & profitability

Figure 14: Boehringer Ingelheim GmbH: assets & liabilities

Figure 15: F. Hoffmann-La Roche Ltd: revenues & profitability

Figure 16: F. Hoffmann-La Roche Ltd: assets & liabilities

Figure 17: Merck & Co., Inc.: revenues & profitability

Figure 18: Merck & Co., Inc.: assets & liabilities

List of Tables

Table 1: Europe biotechnology industry value: USD billion, 2013-17

Table 2: Europe biotechnology industry category segmentation: USD billion, 2017

Table 3: Europe biotechnology industry geography segmentation: USD billion, 2017

Table 4: Europe biotechnology industry value forecast: USD billion, 2017-22

Table 5: AstraZeneca PLC: key facts

Table 6: AstraZeneca PLC: key financials (USD )

Table 7: AstraZeneca PLC: key financial ratios

Table 8: Boehringer Ingelheim GmbH: key facts

Table 9: Boehringer Ingelheim GmbH: key financials (USD )

Table 10: Boehringer Ingelheim GmbH: key financials (EUR)

Table 11: Boehringer Ingelheim GmbH: key financial ratios

Table 12: F. Hoffmann-La Roche Ltd: key facts

Table 13: F. Hoffmann-La Roche Ltd: key financials (USD )

Table 14: F. Hoffmann-La Roche Ltd: key financials (CHF)

Table 15: F. Hoffmann-La Roche Ltd: key financial ratios

Table 16: Merck & Co., Inc.: key facts

Table 17: Merck & Co., Inc.: key financials (USD )

Table 18: Merck & Co., Inc.: key financial ratios

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand

person